부산대학교 도서관

van den Bent, Martin J ; Klein, Martin ; Smits, Marion ; Reijneveld, Jaap C ; French, Pim J ; Clement, Paul ; de Vos, Filip Y F ; Wick, Antje ; Mulholland, Paul J ; Taphoorn, Martin J B ; Lewis, Joanne ; Weller, Michael ; Chinot, Olivier L ; Kros, Johan M ; de Heer, Iris ; Verschuere, Tina ; Coens, Corneel ; Golfinopoulos, Vassilis ; Gorlia, Thierry ; Idbaih, Ahmed

In The Lancet Oncology September 2018 19(9):1170-1179

Liau, Linda M; Ashkan, Keyoumars; Brem, Steven; Campian, Jian L; Trusheim, John E; Iwamoto, Fabio M; Tran, David D; Ansstas, George; Cobbs, Charles S; Heth, Jason A; Salacz, Michael E; D’Andre, Stacy; Aiken, Robert D; Moshel, Yaron A; Nam, Joo Y; Pillainayagam, Clement P; Wagner, Stephanie A; Walter, Kevin A; Chaudhary, Rekha; Goldlust, Samuel A; Lee, Ian Y; Bota, Daniela A; Elinzano, Heinrich; Grewal, Jai; Lillehei, Kevin; Mikkelsen, Tom; Walbert, Tobias; Abram, Steven; Brenner, Andrew J; Ewend, Matthew G; Khagi, Simon; Lovick, Darren S; Portnow, Jana; Kim, Lyndon; Loudon, William G; Martinez, Nina L; Thompson, Reid C; Avigan, David E; Fink, Karen L; Geoffroy, Francois J; Giglio, Pierre; Gligich, Oleg; Krex, Dietmar; Lindhorst, Scott M; Lutzky, Jose; Meisel, Hans-Jörg; Nadji-Ohl, Minou; Sanchin, Lhagva; Sloan, Andrew; Taylor, Lynne P; Wu, Julian K; Dunbar, Erin M; Etame, Arnold B; Kesari, Santosh; Mathieu, David; Piccioni, David E; Baskin, David S; Lacroix, Michel; May, Sven-Axel; New, Pamela Z; Pluard, Timothy J; Toms, Steven A; Tse, Victor; Peak, Scott; Villano, John L; Battiste, James D; Mulholland, Paul J; Pearlman, Michael L; Petrecca, Kevin; Schulder, Michael; Prins, Robert M; Boynton, Alton L; Bosch, Marnix L

JAMA Oncology, vol 9, iss 1

Tesileanu CMS; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Sanson M; Sorbonne Universités UPMC University of Paris 06, Inserm, CNRS, APHP, Institut du Cerveau et de la Moelle (ICM)-Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, 75013, Paris, France.; Taal W; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.; Wick W; Neurologische Klinik und Nationales Zentrum für Tumorerkrankungen Universitätsklinik, Heidelberg, Germany.; Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy.; Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium.; Chinot OL; Neuro-Oncology Division, Aix-Marseille University, AP-HM, Marseille, France.; Wheeler H; Northern Sydney Cancer Centre, St Leonards, NSW, 2065, Australia.; Gill S; Department Medical Oncology, Alfred Hospital, Melbourne, Australia.; Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA.; Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; McBain C; Department of Clinical Oncology, The Christie NHS FT, Manchester, UK.; Reijneveld J; Brain Tumor Center Amsterdam and Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Enting RH; Department of Neurology, UMCG, University of Groningen, Groningen, The Netherlands.; Caparrotti F; Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.; Lesimple T; Department of Clinical Oncology, Comprehensive Cancer Center Eugène Marquis, Rennes, France.; Clenton S; Weston Park Hospital, Sheffield, UK.; Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Lim E; Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK.; de Vos F; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.; Mulholland PJ; University College Hospital, London, UK.; Taphoorn MJB; MC Haaglanden, Den Haag, The Netherlands.; de Heer I; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; de Wit M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Boggiani L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Venneker S; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Erridge S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburg, UK.; Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA.; Nowak AK; School of Medicine and Pharmacology, University of Western Australia, 35 Stirling, Highway Crawley, WA, 6009, Australia.; CoOperative Group for NeuroOncology, University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA, 6009, Australia.; Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Kros JM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.; Aldape K; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Dubbink HJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Baumert B; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Center (MUMC) and GROW (School for Oncology), Maastricht, The Netherlands.; Institute of Radiation-Onology, Chur, Switzerland.; Golfinopoulos V; EORCT HQ, Brussels, Belgium.; Gorlia T; EORCT HQ, Brussels, Belgium.; van den Bent M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. p.french@erasmusmc.nl.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Reijneveld JC; Department of Neurology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; SEIN, Heemstede, the Netherlands. Electronic address: jc.reijneveld@amsterdamumc.nl.; Machingura A; EORTC Headquarters,Brussels, Belgium.; Coens C; EORTC Headquarters,Brussels, Belgium.; Taphoorn MJB; Leiden University Medical Center, Leiden and Haaglanden Medical Center, The Hague, the Netherlands.; Taal W; Department of Neurology, Erasmus MC Cancer Institute, Dr. Molenwaterplein 40, PO Box 2040, 3015 GD, Rotterdam, the Netherlands.; Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.; Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière, Charles Foix, DMU Neurosciences, Servicede Neurologie 2-Mazarin, F-75013, Paris, France.; de Vos FYF; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.; Klein M; Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081HV, Amsterdam, the Netherlands.; Wick W; Universitaets Klinikum Heidelberg, Head Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Mulholland PJ; University College Hospital, 235 Euston Road, NW1 2BU, London,UK.; Lewis J; Newcastle Hospitals NHS Trust, Freeman Hospital, Northern Centre for Cancer Care, Freeman Road, High Heaton, NE7 7DN, Newcastle upon Tyne, UK.; Golfinopoulos V; EORTC Headquarters,Brussels, Belgium.; Ghislain I; EORTC Headquarters,Brussels, Belgium.; Bottomley A; EORTC Headquarters,Brussels, Belgium.; van den Bent MJ; Erasmus MC, Dr. Molenwaterplein 40, PO Box 2040, 3015 GD Rotterdam, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Draaisma K; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Tesileanu CMS; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; de Heer I; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Klein M; Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands.; Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.; Reijneveld JC; Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands.; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.; Clement PM; Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium.; de Vos FYF; UMC Utrecht, Utrecht, the Netherlands.; Wick A; Heidelberg University MC, Heidelberg, Germany.; Mulholland PJ; University College, London, United Kingdom.; Taphoorn MJB; MC Haaglanden, The Hague, the Netherlands.; Leiden UMC, Leiden, the Netherlands.; Weller M; University Hospital Zurich, Zurich, Switzerland.; Chinot OL; Hôpital de la Timone, Marseille, France.; Kros JM; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands.; Verschuere T; EORTC Headquarters, Brussels, Belgium.; Coens C; EORTC Headquarters, Brussels, Belgium.; Golfinopoulos V; EORTC Headquarters, Brussels, Belgium.; Gorlia T; EORTC Headquarters, Brussels, Belgium.; Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpital de la Pitié Salpêtrière, DMU Neurosciences, Paris, France.; Robe PA; UMC Utrecht, Utrecht, the Netherlands.; van den Bent MJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; French PJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Rampling R; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.; Peoples S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, Edinburgh, United Kingdom.; Mulholland PJ; Department of Oncology, University College London Hospitals, London, United Kingdom.; James A; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.; Al-Salihi O; Adult Neuro-Oncology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom.; Twelves CJ; Cancer Research UK Clinical Centre, St James's University Hospital, Leeds, United Kingdom.; McBain C; The Christie NHS Foundation Trust, Withington, Manchester, United Kingdom.; Jefferies S; Cambridge Cancer Trials Centre, Oncology Clinical Trials, Addensbrooke's Hospital, Cambridge, United Kingdom.; Jackson A; Wolfson Molecular Imaging Centre, University of Manchester, Manchester, United Kingdom.; Stewart W; Department of Neuropathology, The Queen Elizabeth University Hospital, Glasgow, United Kingdom.; Lindner J; Immatics Biotechnologies GmbH, Tübingen, Germany.; Kutscher S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hilf N; Immatics Biotechnologies GmbH, Tübingen, Germany.; McGuigan L; Cancer Research UK Centre for Drug Development, London, United Kingdom.; Peters J; Cancer Research UK Centre for Drug Development, London, United Kingdom.; Hill K; Cancer Research UK Centre for Drug Development, London, United Kingdom.; Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany.; Singh-Jasuja H; Immatics Biotechnologies GmbH, Tübingen, Germany.; Halford SE; Cancer Research UK Centre for Drug Development, London, United Kingdom.; Ritchie JW; Cancer Research UK Centre for Drug Development, London, United Kingdom. james.ritchie@cancer.org.uk.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Power DG; Department of Medical Oncology, St. James's Hospital, Dublin, Ireland. drdgpower@gmail.com; Galvin DJ; Cuffe S; McVey GP; Mulholland PJ; Farrelly C; Delaney DW; O'Byrne KJ

Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1078-1439 (Print) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

Mulholland PJ; Human Cytogenetics Laboratory, Cancer Research, UK.; Fiegler H; Mazzanti C; Gorman P; Sasieni P; Adams J; Jones TA; Babbage JW; Vatcheva R; Ichimura K; East P; Poullikas C; Collins VP; Carter NP; Tomlinson IP; Sheer D

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1551-4005 (Electronic) Linking ISSN: 15514005 NLM ISO Abbreviation: Cell Cycle Subsets: MEDLINE

Mulholland PJ; Department of Medical Oncology, Charing Cross Hospital, Imperial College of Medicine, London W6 8RF, UK. Paul.Mulholland@cancer.org.uk; Thirlwell C; Brock CS; Newlands ES

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE